Clinical trial
Perennial Malaria Chemoprevention in the Malaria Vaccine Era
NCT07322068 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Perennial Malaria Chemoprevention in the Malaria Vaccine Era
- Lead sponsor
- Stanford University
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- September 30, 2026
- Completion date
- June 30, 2033
- Enrollment
- 1,290 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.